TORRENT PHARMTORRENT PHARMTORRENT PHARM

TORRENT PHARM

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪997.91 B‬INR
‪16.56 B‬INR
‪106.05 B‬INR
‪96.79 M‬
Beta (1Y)
0.28

About TORRENT PHARM

Headquarters
Ahmedabad
Employees (FY)
‪16.15 K‬
Founded
1959
ISIN
INE685A01028
FIGI
BBG000D80XY7
Torrent Pharmaceuticals Ltd. engages in the research, development, manufacture, and marketing of generic pharmaceutical formulations. It offers pharmaceutical products to local and international markets, particularly in countries such as India, USA, Germany, Brazil, and other countries. The company was founded by Uttambhai Nathalal Mehta in 1959 and is headquartered in Ahmedabad, India.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of TORNTPHARM is 3,029.80 INR — it has increased by 2.83% in the past 24 hours. Watch TORRENT PHARM stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange TORRENT PHARM stocks are traded under the ticker TORNTPHARM.
TORNTPHARM stock has risen by 2.71% compared to the previous week, the month change is a 6.01% rise, over the last year TORRENT PHARM has showed a 58.21% increase.
We've gathered analysts' opinions on TORRENT PHARM future price: according to them, TORNTPHARM price has a max estimate of 3,285.00 INR and a min estimate of 2,520.00 INR. Watch TORNTPHARM chart and read a more detailed TORRENT PHARM stock forecast: see what analysts think of TORRENT PHARM and suggest that you do with its stocks.
TORNTPHARM reached its all-time high on Jul 18, 2024 with the price of 3,073.95 INR, and its all-time low was 4.05 INR and was reached on Dec 1, 1998. View more price dynamics on TORNTPHARM chart.
See other stocks reaching their highest and lowest prices.
TORNTPHARM stock is 6.09% volatile and has beta coefficient of 0.28. Track TORRENT PHARM stock price on the chart and check out the list of the most volatile stocks — is TORRENT PHARM there?
Today TORRENT PHARM has the market capitalization of ‪997.91 B‬, it has increased by 2.86% over the last week.
Yes, you can track TORRENT PHARM financials in yearly and quarterly reports right on TradingView.
TORRENT PHARM is going to release the next earnings report on Jul 23, 2024. Keep track of upcoming events with our Earnings Calendar.
TORNTPHARM earnings for the last quarter are 13.30 INR per share, whereas the estimation was 13.59 INR resulting in a −2.12% surprise. The estimated earnings for the next quarter are 13.87 INR per share. See more details about TORRENT PHARM earnings.
TORRENT PHARM revenue for the last quarter amounts to ‪27.45 B‬ INR, despite the estimated figure of ‪27.78 B‬ INR. In the next quarter, revenue is expected to reach ‪28.86 B‬ INR.
TORNTPHARM net income for the last quarter is ‪4.49 B‬ INR, while the quarter before that showed ‪4.43 B‬ INR of net income which accounts for 1.35% change. Track more TORRENT PHARM financial stats to get the full picture.
As of Jul 22, 2024, the company has ‪16.15 K‬ employees. See our rating of the largest employees — is TORRENT PHARM on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TORRENT PHARM EBITDA is ‪33.68 B‬ INR, and current EBITDA margin is 31.39%. See more stats in TORRENT PHARM financial statements.
Like other stocks, TORNTPHARM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TORRENT PHARM stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TORRENT PHARM technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TORRENT PHARM stock shows the strong buy signal. See more of TORRENT PHARM technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.